Cargando…

Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico

At the end of 2020 and previous to the second wave of COVID-19 in Mexico, the seroprevalence in unvaccinated people in the state of Campeche, Mexico was below 15 %. The prevalence changes with ongoing pandemic and per geographical areas. Blood donors screening is a powerful and cost-effective altern...

Descripción completa

Detalles Bibliográficos
Autores principales: Monteón, Victor, Pérez, Floribeth Leon, Hernández, Virginia Peña, Pacheco, Anatalia Osorio, Guzman, Pedro Fuentes, Torres, Gicel Ivett Gutiérrez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801968/
https://www.ncbi.nlm.nih.gov/pubmed/35101375
http://dx.doi.org/10.1016/j.transci.2022.103374
_version_ 1784642571643912192
author Monteón, Victor
Pérez, Floribeth Leon
Hernández, Virginia Peña
Pacheco, Anatalia Osorio
Guzman, Pedro Fuentes
Torres, Gicel Ivett Gutiérrez
author_facet Monteón, Victor
Pérez, Floribeth Leon
Hernández, Virginia Peña
Pacheco, Anatalia Osorio
Guzman, Pedro Fuentes
Torres, Gicel Ivett Gutiérrez
author_sort Monteón, Victor
collection PubMed
description At the end of 2020 and previous to the second wave of COVID-19 in Mexico, the seroprevalence in unvaccinated people in the state of Campeche, Mexico was below 15 %. The prevalence changes with ongoing pandemic and per geographical areas. Blood donors screening is a powerful and cost-effective alternative to monitor the population’s infection exposure. The aim of the study was to estimate IgG anti-SARS-CoV-2 seropositivity in the Campeche’s main blood bank in Mexico. This was a cross-sectional study carried out at the main blood bank of the State of Campeche, located in the Yucatan peninsula, Mexico for the period of August through September 2021 during the third wave of the epidemic. A blood sample from 479 blood donors were included in the study, the overall seropositivity for SARS-CoV-2 IgG antibodies was 69.1 %. Vaccinated donors represented 69.9 % versus 29.4 % unvaccinated. The seropositivity in unvaccinated represented 42.5 % and 81.17 % in vaccinated. The seroconversion in vaccinated donors after first shot was 79 % for Astra-Zeneca-vaccine and 90 % for Pfizer-vaccine. In conclusion 69.1 % of blood donors are seropositive for SARS-CoV-2 and 42.5 percent unvaccinated people are already also seropositive.
format Online
Article
Text
id pubmed-8801968
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-88019682022-01-31 Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico Monteón, Victor Pérez, Floribeth Leon Hernández, Virginia Peña Pacheco, Anatalia Osorio Guzman, Pedro Fuentes Torres, Gicel Ivett Gutiérrez Transfus Apher Sci Article At the end of 2020 and previous to the second wave of COVID-19 in Mexico, the seroprevalence in unvaccinated people in the state of Campeche, Mexico was below 15 %. The prevalence changes with ongoing pandemic and per geographical areas. Blood donors screening is a powerful and cost-effective alternative to monitor the population’s infection exposure. The aim of the study was to estimate IgG anti-SARS-CoV-2 seropositivity in the Campeche’s main blood bank in Mexico. This was a cross-sectional study carried out at the main blood bank of the State of Campeche, located in the Yucatan peninsula, Mexico for the period of August through September 2021 during the third wave of the epidemic. A blood sample from 479 blood donors were included in the study, the overall seropositivity for SARS-CoV-2 IgG antibodies was 69.1 %. Vaccinated donors represented 69.9 % versus 29.4 % unvaccinated. The seropositivity in unvaccinated represented 42.5 % and 81.17 % in vaccinated. The seroconversion in vaccinated donors after first shot was 79 % for Astra-Zeneca-vaccine and 90 % for Pfizer-vaccine. In conclusion 69.1 % of blood donors are seropositive for SARS-CoV-2 and 42.5 percent unvaccinated people are already also seropositive. Elsevier Ltd. 2022-06 2022-01-31 /pmc/articles/PMC8801968/ /pubmed/35101375 http://dx.doi.org/10.1016/j.transci.2022.103374 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Monteón, Victor
Pérez, Floribeth Leon
Hernández, Virginia Peña
Pacheco, Anatalia Osorio
Guzman, Pedro Fuentes
Torres, Gicel Ivett Gutiérrez
Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
title Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
title_full Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
title_fullStr Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
title_full_unstemmed Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
title_short Seroprevalence of SARS-CoV-2 antibodies in blood donors during the third wave of infection in Campeche Mexico
title_sort seroprevalence of sars-cov-2 antibodies in blood donors during the third wave of infection in campeche mexico
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801968/
https://www.ncbi.nlm.nih.gov/pubmed/35101375
http://dx.doi.org/10.1016/j.transci.2022.103374
work_keys_str_mv AT monteonvictor seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico
AT perezfloribethleon seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico
AT hernandezvirginiapena seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico
AT pachecoanataliaosorio seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico
AT guzmanpedrofuentes seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico
AT torresgicelivettgutierrez seroprevalenceofsarscov2antibodiesinblooddonorsduringthethirdwaveofinfectionincampechemexico